Simulation Modeling for Adaptive Protocols in Rare Disease Trials
Simulation Modeling for Adaptive Protocols in Rare Disease Trials Leveraging Simulation Modeling to Optimize Adaptive Protocols in Rare Disease Trials Introduction: Why Simulation Is Crucial in Rare Disease Clinical Trials Designing clinical trials for rare and orphan diseases is inherently complex due to small sample sizes, high inter-patient variability, and uncertain natural history data. Adaptive…
Read More “Simulation Modeling for Adaptive Protocols in Rare Disease Trials” »